Dr. Derek Alexander Wierzbicki, MD

Dr. Wierzbicki practices at Pascagoula Hospital in Pascagoula, Mississippi, part of State of Mississippi.

Dr. Wierzbicki's NPI, 1780799288, was assigned on August 21, 2006. Dr. Wierzbicki graduated from University of Texas Medical School at Houston in 2002. Dr. Wierzbicki holds Louisiana license MD.026276.

Dr. Wierzbicki's primary practice is Pascagoula Hospital, at 2809 Denny Av, Pascagoula, MS 39581 in Jackson County. The practice phone is (228) 809-5000.

Dr. Wierzbicki's primary practice is Pascagoula Hospital in Pascagoula, Mississippi, part of State of Mississippi. Dr. Wierzbicki is also affiliated with Singing River Gulfport. The medical group on file is American Physician Partners. Dmand AI also links Dr. Wierzbicki to 3 more hospitals, 18 medical groups and 10 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wierzbicki practices, 15 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Wierzbicki's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. Wierzbicki is licensed in Louisiana.

CMS data shows 357 Medicare services from Dr. Wierzbicki across 3 procedure codes in 2024, for 345 Medicare patients. Medicare paid $43,776 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 345 Medicare patients who saw Dr. Wierzbicki in 2024. The largest group is 65 to 74, with 110 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 27% are also on Medicaid. Their average risk score is 2.03, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wierzbicki's median patient age at 59, with 59% women.

In 2024, Dr. Wierzbicki wrote 1,027 Medicare Part D claims for 506 patients. 90% of them were for generic drugs. CMS names the drug for 728 of them, across 25 drugs with 11 or more claims each, at $6,960 in total drug cost. In 2023, CMS named 472 claims across 18 drugs.

Dr. Wierzbicki accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 5 general payments to Dr. Wierzbicki from 3 drug and device companies from 2017 to 2023. Food and beverage make up the largest share, 100% of the total. Inari Medical, Inc. paid the most, $374.

Dr. Wierzbicki graduated from University of Texas Medical School at Houston in 2002.